Related references
Note: Only part of the references are listed.Mouse Model of Necrotic Tuberculosis Granulomas Develops Hypoxic Lesions
Jamie Harper et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Successful Shortening of Tuberculosis Treatment Using Adjuvant Host-Directed Therapy with FDA-Approved Phosphodiesterase Inhibitors in the Mouse Model
Mamoudou Maiga et al.
PLOS ONE (2012)
Phosphodiesterase-4 Inhibition Combined with Isoniazid Treatment of Rabbits with Pulmonary Tuberculosis Reduces Macrophage Activation and Lung Pathology
Selyakumar Subbian et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Phosphodiesterase 4 Inhibition Reduces Innate Immunity and Improves Isoniazid Clearance of Mycobacterium tuberculosis in the Lungs of Infected Mice
Mi-Sun Koo et al.
PLOS ONE (2011)
Penitentiary or penthouse condo: the tuberculous granuloma from the microbe's point of view
Carleitta Paige et al.
CELLULAR MICROBIOLOGY (2010)
Metabolism of Fostamatinib, the Oral Methylene Phosphate Prodrug of the Spleen Tyrosine Kinase Inhibitor R406 in Humans: Contribution of Hepatic and Gut Bacterial Processes to the Overall Biotransformation
David J. Sweeny et al.
DRUG METABOLISM AND DISPOSITION (2010)
The Safety and Efficacy of a JAK Inhibitor in Patients With Active Rheumatoid Arthritis Results of a Double-Blind, Placebo-Controlled Phase IIa Trial of Three Dosage Levels of CP-690,550 Versus Placebo
Joel M. Kremer et al.
ARTHRITIS AND RHEUMATISM (2009)
Adalimumab Treatment of Life-Threatening Tuberculosis
Robert S. Wallis et al.
CLINICAL INFECTIOUS DISEASES (2009)
Analysis of Mycobacterium tuberculosis-Specific CD8 T-Cells in Patients with Active Tuberculosis and in Individuals with Latent Infection
Nadia Caccamo et al.
PLOS ONE (2009)
Therapeutic Use of Infliximab in Tuberculosis to Control Severe Paradoxical Reaction of the Brain and Lymph Nodes
Timothy K. Blackmore et al.
CLINICAL INFECTIOUS DISEASES (2008)
Eliminating human tuberculosis in the twenty-first century
Christopher Dye et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2008)
Neutralization of tumor necrosis factor (TNF) by antibody but not TNF receptor fusion molecule exacerbates chronic murine tuberculosis
Hillarie L. Plessner et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Pharmacodynamic effects of the murine p75-Fc fusion protein in mice
Yi-Ling Hu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2007)
Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis
Rik J. U. Lories et al.
ARTHRITIS AND RHEUMATISM (2007)
Reconsidering adjuvant immunotherapy for tuberculosis
RS Wallis
CLINICAL INFECTIOUS DISEASES (2005)
Ipr1 gene mediates innate immunity to tuberculosis
H Pan et al.
NATURE (2005)
A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis
RS Wallis et al.
AIDS (2004)
Granulomatous infectious diseases associated with tumor necrosis factor antagonists
RS Wallis et al.
CLINICAL INFECTIOUS DISEASES (2004)
Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
J Keane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
